However, these two basal/SCC‐like tumour categories do not differ in their KRT5, KRT14/FOXA1, GATA3 ratios, their defining characteristics, or their shifts to high CDH3 and lower CDH1 expression. This evidence concerns the gene CDH3 and neoplasm.